Euradia Nuklearmedizin

What Euradia Nuklearmedizin does

Euradia Nuklearmedizin is a single-site German nuclear medicine practice (MVZ) headquartered at Stobenstraße 1-6 in central Braunschweig, operating as the legal entity evidia Nuklearmedizin Braunschweig GmbH under the Evidia Group. Founded as a nuclear medicine department in 2004 and established as an independent MVZ on April 1, 2015 under medical director Jens Döhring, the practice employs approximately 20 staff including two specialist physicians (Fachärzte für Nuklearmedizin) and one Weiterbildungsassistentin. Its service portfolio spans diagnostic scintigraphy (thyroid, bone, cardiac, kidney, lung, parathyroid, inflammation) and radionuclide therapies (radiosynovectomy, Samarium-153 bone pain therapy, with radioiodine therapy delivered at affiliated inpatient facilities), supported by an on-site RIA/ELISA laboratory and a fully digitized PACS archive.

The practice operates a capital-intensive equipment footprint on more than 430 m², including four gamma cameras (two SPECT-capable dual-head systems), three sonography units, a C-arm for radiosynovectomy, and 4DM-SPECT cardiac function analysis software. Euradia describes itself as the largest nuclear medicine practice in southeastern Lower Saxony since 2009 and as one of the largest thyroid outpatient clinics, bone scintigraphy providers, and radiosynovectomy centers in the state, drawing patients from Braunschweig, Wolfenbüttel, Wolfsburg, Helmstedt, Gifhorn, Peine, and Salzgitter.

The business model is reimbursement-driven under the German healthcare system: services are billed to statutory health insurance (GKV) at EBM rates and to private insurers (PKV) at GOÄ rates, with patients entering the practice exclusively via physician referrals (Überweisung). A service partnership with Städtisches Klinikum Wolfenbüttel, won through a Europe-wide tender in 2011, extends the practice's reach into adjacent catchment areas. There is no disclosed digital, subscription, or DTC revenue stream; the entire model is anchored to referral-based clinical throughput within a regulated, fee-for-service framework.

Name

Euradia Nuklearmedizin

Legal name

evidia Nuklearmedizin Braunschweig GmbH

Website

https://euradia-nuklearmedizin.de

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Short description

Euradia Nuklearmedizin is a Braunschweig-based nuclear medicine MVZ (part of the Evidia Group) providing diagnostic scintigraphy and radionuclide therapy to insured patients across southeastern Lower Saxony via physician referrals, operating since 2004 under medical director Jens Döhring.

Ownership category

akta.pro rank

Product category

Nuclear Medicine Diagnostics and Therapy

NAICS

Diagnostic Imaging Centers (621512), Medical and Diagnostic Laboratories (62151)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro industry

PRIMARYHLAIAGAI

Nuclear Medicine Clinical Services & Therapy Centers

Healthcare & Life Sciences/Pharmaceuticals/Radiopharmaceuticals & Nuclear Medicine

SECONDARYHLAFAKAB

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)

Healthcare & Life Sciences/Healthcare Providers & Systems/Diagnostic & Imaging Centers

SECONDARYHLAIAGAB

Therapeutic Radiopharmaceuticals (Radioligand/Targeted Radionuclide Therapy)

Healthcare & Life Sciences/Pharmaceuticals/Radiopharmaceuticals & Nuclear Medicine

Keywords

• Nuclear medicine diagnostics
• Thyroid diagnostic services
• Scintigraphy imaging
• Radionuclide therapy
• Medical imaging services

Headquarters

HQ city

Braunschweig

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Others

Revenue model

1. Statutory Health Insurance (GKV) Services: The practice treats statutory health insurance patients (gesetzlich Krankenversicherte) who require electronic health insurance card and mandatory referral for nuclear medicine examinations. Revenue is generated through the German statutory health insurance system reimbursement.
2. Private Health Insurance (PKV) Services: Services for privately insured patients (privat Krankenversicherte) who pay according to private fee schedules (GOÄ).

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Euradia Nuklearmedizin operates a modern nuclear medicine medical practice (MVZ) in Braunschweig providing diagnostic imaging and radionuclide therapy. Core services include thyroid diagnostics and therapy, bone scintigraphy, myocardial scintigraphy, kidney scintigraphy, and radiosynovectomy (RSO), supported by an in-house laboratory and modern equipment including four gamma cameras with two SPECT-capable dual-head systems.

Product overview

Euradia Nuklearmedizin is a modern nuclear medicine practice offering a comprehensive portfolio of diagnostic and therapeutic services. The core offering centers on thyroid diagnostics and therapy (Schilddrüsenuntersuchung), making it one of the largest thyroid clinics in Lower Saxony. The practice provides bone scintigraphy (Knochenszintigraphie), heart scintigraphy (Herzszintigraphie), kidney scintigraphy (Nierenszintigraphie), and radiosynoviorthesis (Radiosynoviorthese) as major diagnostic and therapeutic services. Additional examinations include lung scintigraphy, parathyroid scintigraphy, inflammation scintigraphy, and Samarium-153 pain therapy. The practice operates an in-house laboratory for thyroid parameters and uses four gamma cameras (including two SPECT-capable dual-head systems), three sonography devices, and a C-arm. Services are provided at the Braunschweig location at Stobenstraße with a team of 20 employees including two specialist physicians.

Differentiator

Problem solved

Functional benefit

Products and services

• Thyroid Examination (Schilddrüsenuntersuchung) Comprehensive thyroid examination combining sonography, scintigraphy, suppression scintigraphy, fine-needle aspiration, and laboratory tests to assess thyroid morphology and function, for patients with suspected thyroid dysfunction, autoimmune thyroid disease (Hashimoto-Thyreoiditis, Morbus Basedow), nodules, or pre-surgical planning.
• Bone Scintigraphy (Knochenszintigraphie) Nuclear medicine functional diagnostics visualizing bone metabolism in the skeletal system to detect bone metastases, inflammatory changes, healing fractures, and implant loosening, primarily for oncology patients and orthopedic indications.
• Heart Scintigraphy (Herzszintigraphie / Myokardszintigraphie) Nuclear medicine functional diagnostics of the heart muscle under stress and rest conditions to assess myocardial blood flow, detect ischemia, infarct scarring, and pump function (ejection fraction) using 4DM-SPECT analysis.
• Kidney Scintigraphy (Nierenszintigraphie) Nuclear medicine functional diagnostics assessing kidney blood flow and excretion function, including total kidney function, side proportions, drainage assessment, and renal artery stenosis diagnosis.
• Radiosynovectomy / Radiosynoviorthesis (RSO) Therapeutic injection of radionuclides (Erbium-169, Rhenium-186, Yttrium-90) into inflamed joints under C-arm fluoroscopy guidance to treat inflammatory joint diseases, activated arthrosis, and post-prosthesis synovial irritation.
• Lung Scintigraphy (Lungenszintigraphie) Combined ventilation and perfusion scintigraphy of the lungs for diagnosing pulmonary embolism.
• Parathyroid Scintigraphy (Nebenschilddrüsenszintigraphie) Diagnostic imaging using Technetium-99m-MIBI scintigraphy to localize parathyroid adenomas or hyperplasia for surgical planning.
• Inflammation Scintigraphy (Entzündungsszintigraphie / Leukocyte Scintigraphy) Diagnostic imaging using Technetium-99m-labeled anti-granulocyte antibodies or fragments to detect inflammatory processes, osteomyelitis, prosthesis infections, and fever of unknown origin.
• Samarium-153 Pain Therapy (Samariumtherapie) Pain treatment for bone metastases using Samarium-153 (Quadramet), a beta emitter absorbed by osteoblastic bone metastases from breast and prostate cancer.
• Radioiodine Therapy (Radiojodtherapie with Iodine-131) Therapy with Iodine-131 for treating thyroid conditions including warm nodules, diffuse autonomy, Morbus Basedow, and thyroid cancer residual ablation; performed inpatient at affiliated hospital facilities in Germany.

Quantifiable outcome

• Bone scintigraphy achieves approximately 94% sensitivity for detecting bone lesions
• +2 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Städtisches Klinikum WolfenbüttelcoreStrategic or Co-development Partner · 1 January 2011Euradia provides radiological and nuclear medicine services at Städtisches Klinikum Wolfenbüttel since 2011, after winning a Europe-wide tender process. Nuclear medicine services were provided at the Wolfenbüttel location from 2011-2014. The practice continues to provide nuclear medicine coverage for the hospital.
• Evidia Group (evidia Nuklearmedizin Braunschweig GmbH)coreOthersEuradia Nuklearmedizin is an MVZ (medical care center) under evidia Nuklearmedizin Braunschweig GmbH, part of the Evidia Group. The practice became independently operated on April 1, 2015 under the leadership of Jens Döhring while maintaining affiliation with the Evidia network.

Scale indicators6 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Evidia Group: Evidia is the parent network/operating company of evidia Nuklearmedizin Braunschweig GmbH (Euradia's legal entity) and operates multiple nuclear medicine MVZ practices across Germany under a similar referral-based, radiopharmaceutical-driven model. Most directly comparable as the operating network Euradia sits within.
• Conradia Radiologie & Nuklearmedizin: Conradia operates a network of radiology and nuclear medicine practices/MVZ sites across Germany offering SPECT, scintigraphy, and radiopharmaceutical-based therapy under similar statutory/private reimbursement. Directly comparable as a multi-site German nuclear medicine practice group.
• Med 360°: Med 360° is a German operator of radiology and nuclear medicine MVZ centers with regional hubs offering gamma-camera-based diagnostics and radiopharmaceutical therapy. Comparable as a multi-site German diagnostic imaging/nuclear medicine group serving similar referral channels.
• Radiologie und Nuklearmedizin - Städtisches Klinikum Wolfenbüttel: Städtisches Klinikum Wolfenbüttel is Euradia's existing partner site where Euradia has provided radiology and nuclear medicine services since 2011. Comparable as the hospital counterpart that channels inpatient and outpatient nuclear medicine demand to/from Euradia.
• Radiomed Wiesbaden: Radiomed is a German MVZ practice combining radiology and nuclear medicine diagnostics (including SPECT) under the same referral-driven, statutory-insurance reimbursement model. Comparable as a regional German nuclear medicine/radiology practice.
• MediaPark Klinik Köln: MediaPark Klinik in Cologne operates a nuclear medicine department performing thyroid, bone, cardiac, and renal scintigraphy along with radionuclide therapy for ambulatory patients. Comparable as a German ambulatory nuclear medicine provider with a similar service mix.

Broad incumbents

• Universitätsklinikum - Klinik für Nuklearmedizin (representative German academic centers, e.g., MHH Hannover): Medizinische Hochschule Hannover (MHH) and similar German university hospitals operate nuclear medicine departments offering the full range of scintigraphy, SPECT/PET, and radionuclide therapy. Comparable as large incumbents with deeper subspecialty depth but slower ambulatory throughput than Euradia.
• Helios Kliniken (nuclear medicine departments): Helios is a large German private hospital group with nuclear medicine departments at multiple sites offering SPECT, scintigraphy, and radionuclide therapy. Comparable as a broad incumbent providing overlapping nuclear medicine services within hospital settings.

Emerging players

• Medneo Deutschland: Medneo operates a German network of outpatient radiology/imaging centers using standardized workflows and modern equipment. Comparable as a tech-enabled, multi-site outpatient imaging platform that may compete for nuclear medicine referrals in shared catchment areas.

Regional players

• Diagnostik München: Diagnostik München is a Munich-based diagnostic center offering nuclear medicine imaging and laboratory diagnostics under similar GKV/PKV reimbursement dynamics. Comparable as a regional German diagnostic imaging competitor with overlapping modality mix.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/euradia-nuklearmedizin

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Euradia Nuklearmedizin